ArticleTrials2022

Sequencing Mycobacteria and Algorithm-determined Resistant Tuberculosis Treatment (SMARTT): a study protocol for a phase IV pragmatic randomized controlled patient management strategy trial.

Annelies Van Rie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.